Precigen, Inc. (PGEN) News
Track canonical SquawkNews coverage tagged to PGEN, Precigen, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Precigen director sold shares worth over $1.3M
A Precigen director sold shares worth over $1.3M.
EQUITY | Aug 29, 2026, 12:40 AM UTC
M
Precigen PGEN touts strong Q2 growth; PRGN-2009 HPV-cancer progress
Precigen (PGEN) reports a strong second quarter, saying it signals significant growth and validates its AdenoVerse platform, while highlighting PRGN-2009 advances in HPV-driven cancers.
EQUITY | Aug 25, 2026, 11:00 AM UTC
L
PGEN September 8 calls offered, 6K at $0.25 expiring Sep. 18
PGEN September 8 call activity is on offer for 6,000 contracts at $0.25, with expiry on Sep. 18; no catalyst was supplied.
EQUITY | Aug 20, 2026, 02:16 PM UTC
H
HC Wainwright Raises PGEN Price Target
Raises PGEN target to $18 from $14
EQUITY | Aug 05, 2026, 11:11 AM UTC
H
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of Arista Networks Inc (NYSE: ANET ) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued strong third-quarter guidance. Arista Networks re
EARNINGS | Aug 05, 2026, 08:57 AM UTC
L
PGEN PGEN - Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
PGEN PGEN - Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
EARNINGS | Aug 04, 2026, 08:02 PM UTC